| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.99T | 7.58T | 7.08T | 6.21T | 5.66T | 5.29T |
| Gross Profit | 4.33T | 3.95T | 3.72T | 3.14T | 3.05T | 2.77T |
| EBITDA | 1.78T | 1.71T | 1.06T | 726.82B | 724.58B | 397.33B |
| Net Income | 1.32T | 1.06T | 695.81B | 374.60B | 420.48B | 161.80B |
Balance Sheet | ||||||
| Total Assets | 30.56T | 31.24T | 30.59T | 27.40T | 27.25T | 25.77T |
| Cash, Cash Equivalents and Short-Term Investments | 1.03T | 1.07T | 896.90B | 871.99B | 848.82B | 812.01B |
| Total Debt | 225.76B | 227.25B | 224.40B | 222.81B | 219.79B | 230.60B |
| Total Liabilities | 25.64T | 26.13T | 25.41T | 23.80T | 23.17T | 22.04T |
| Stockholders Equity | 4.94T | 5.08T | 5.18T | 3.58T | 4.02T | 3.67T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32T | 1.05T | 982.83B | 1.07T | 1.15T |
| Operating Cash Flow | 0.00 | 1.35T | 1.07T | 1.01T | 1.10T | 1.18T |
| Investing Cash Flow | 0.00 | 177.45B | -616.43B | 29.16B | -658.65B | -725.69B |
| Financing Cash Flow | 0.00 | -1.20T | -417.42B | -1.02T | -511.42B | -518.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥5.53T | 7.65 | ― | 2.82% | 11.37% | 27.90% | |
74 Outperform | ¥13.80T | 13.03 | 20.81% | 3.33% | -2.10% | -8.76% | |
72 Outperform | ¥6.05T | 8.22 | 16.97% | 2.59% | 23.01% | 2.59% | |
72 Outperform | ¥1.76T | 17.60 | ― | 2.44% | -21.38% | 58.05% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥5.50T | 7.36 | 10.61% | 3.26% | -8.02% | 5.21% | |
61 Neutral | ¥1.74T | 10.62 | 7.91% | 2.74% | -1.96% | 10.32% |